Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Four-Repeat Tauopathy Neuroimaging Initiative

NCT02966145 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT02966145
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02966145 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Four-Repeat Tauopathy Neuroimaging Initiative
Lead sponsor
University of California, San Francisco
Phase
Observational
Overall status
Completed
Start date
January 31, 2016
Completion date
February 28, 2024
Enrollment
293 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

cortical-basal ganglionic degeneration (cbgd), corticobasal degeneration (cbd), corticobasal syndrome (cbs), nonfluent variant primary progressive aphasia (nfvppa), oligosymptomatic/variant progressive supranuclear palsy (o/vpsp), progressive supranuclear palsy (psp)